Clinical Trial Update: Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update announces the completion of Phase 2 and Phase 3 studies assessing oxyhydrogen nanobubble infusion as a complementary therapy for Parkins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Oxyhydrogen Nanobubble Infusion

Snippet

Sponsor: dr. Siti Nurlaela, SpN | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: COMPLETED